Ronald W Barrett - Net Worth and Insider Trading
Ronald W Barrett Net Worth
The estimated net worth of Ronald W Barrett is at least $3 Million dollars as of 2024-11-13. Ronald W Barrett is the CEO of XenoPort Inc and owns about 359,942 shares of XenoPort Inc (XNPT) stock worth over $3 Million. Ronald W Barrett is also the Director of Concert Pharmaceuticals Inc and owns about 0 shares of Concert Pharmaceuticals Inc (CNCE) stock worth over $0. Details can be seen in Ronald W Barrett's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ronald W Barrett has not made any transactions after 2017-12-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Ronald W Barrett
Ronald W Barrett Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ronald W Barrett owns 3 companies in total, including Concert Pharmaceuticals Inc (CNCE) , XenoPort Inc (XNPT) , and Janux Therapeutics Inc (JANX) .
Click here to see the complete history of Ronald W Barrett’s form 4 insider trades.
Insider Ownership Summary of Ronald W Barrett
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
CNCE | Concert Pharmaceuticals Inc | 2018-06-14 | director |
XNPT | XenoPort Inc | 2015-09-01 | director & Chief Executive Officer |
JANX | Janux Therapeutics Inc | 2021-09-07 | director |
Ronald W Barrett Latest Holdings Summary
Ronald W Barrett currently owns a total of 2 stocks. Among these stocks, Ronald W Barrett owns 359,942 shares of XenoPort Inc (XNPT) as of September 1, 2015, with a value of $3 Million and a weighting of 100%. Ronald W Barrett also owns 0 shares of Concert Pharmaceuticals Inc (CNCE) as of December 4, 2017, with a value of $0 and a weighting of 0%.
Latest Holdings of Ronald W Barrett
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
XNPT | XenoPort Inc | 2015-09-01 | 359,942 | 7.07 | 2,544,790 |
CNCE | Concert Pharmaceuticals Inc | 2017-12-04 | 0 | 8.37 | 0 |
Holding Weightings of Ronald W Barrett
Ronald W Barrett Form 4 Trading Tracker
According to the SEC Form 4 filings, Ronald W Barrett has made a total of 0 transactions in XenoPort Inc (XNPT) over the past 5 years. The most-recent trade in XenoPort Inc is the sale of 12,500 shares on September 1, 2015, which brought Ronald W Barrett around $87,500.
According to the SEC Form 4 filings, Ronald W Barrett has made a total of 0 transactions in Concert Pharmaceuticals Inc (CNCE) over the past 5 years. The most-recent trade in Concert Pharmaceuticals Inc is the sale of 14,156 shares on December 4, 2017, which brought Ronald W Barrett around $349,653.
Insider Trading History of Ronald W Barrett
- 1
Ronald W Barrett Trading Performance
GuruFocus tracks the stock performance after each of Ronald W Barrett's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Ronald W Barrett is 9.43%. GuruFocus also compares Ronald W Barrett's trading performance to market benchmark return within the same time period. The performance of stocks bought by Ronald W Barrett within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Ronald W Barrett's insider trading performs compared to the benchmark.
Performance of Ronald W Barrett
Ronald W Barrett Ownership Network
Ownership Network List of Ronald W Barrett
Ownership Network Relation of Ronald W Barrett
Ronald W Barrett Owned Company Details
What does Concert Pharmaceuticals Inc do?
Who are the key executives at Concert Pharmaceuticals Inc?
Ronald W Barrett is the director of Concert Pharmaceuticals Inc. Other key executives at Concert Pharmaceuticals Inc include Chief Development Officer James V Cassella , CFO & PFO Marc A. Becker , and Chief Operating Officer Nancy Stuart .
Concert Pharmaceuticals Inc (CNCE) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Concert Pharmaceuticals Inc (CNCE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Concert Pharmaceuticals Inc (CNCE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Concert Pharmaceuticals Inc (CNCE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Concert Pharmaceuticals Inc Insider Transactions
Ronald W Barrett Mailing Address
Above is the net worth, insider trading, and ownership report for Ronald W Barrett. You might contact Ronald W Barrett via mailing address: C/o Xenoport, Inc., 3410 Central Expressway, Santa Clara Ca 95051.